Finzati - Logo
MASI logo

Masimo Corporation

MASI • Medical - Devices
$179.95
— 0.00 (0.00%)
Current price
EarningsLatest report: Apr 4, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$9.42B
Growth
28.6%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · -9.9%Positive revenue growth · 6.1%Positive free cash flow · 3.69Consistent free cash flow · 4/5Manageable debt level · 0.78
Financial data as of: Apr 4, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$179.95
Change0.00%
Market Cap$9.42B
52W Range125.94 - 179.99
Beta1.18
Gross Margin61.90%
Oper. Margin20.49%
Profit Margin-9.92%
Debt/Eq0.78
Current Ratio2.49
Quick Ratio1.47
Revenue 5Y28.57%

Investment DNA

How strong this company looks for long-term investors

62
out of 100
Business Quality
Margins, moat, returns
48/100
Financial Strength
Debt, cash, stability
87/100
Growth Potential
Revenue and expansion
48/100
Price Attractiveness
Cheap or expensive today
45/100
Why this score▼
Stable or improving margins · -9.9%Positive revenue growth · 6.1%Positive free cash flow · 3.69Consistent free cash flow · 4/5Manageable debt level · 0.78Healthy liquidity · 2.49

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-23
Low
$180.00
Mean
$180.00
Median
$180.00
High
$180.00

Company Overview

IPO: 8/8/2007
Industry: Medical - Devices
P/B i: 9.47
Debt / Equity i: 0.78
Operating Margin: 20.49%
Net Margin: -9.92%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.78
Current Ratio: 2.49
Quick Ratio: 1.47
Status: Strong

Insider Transactions

Recent executive and insider activity

Szyman Catherine M.
Transaction: 06/10/2026
SELL
Change
-49,243
Price
Not reported
Filing
06/12/2026
Type
SELL
Szyman Catherine M.
Transaction: 06/10/2026
SELL
Change
-18,617
Price
$166.52
Filing
06/12/2026
Type
SELL
Szyman Catherine M.
Transaction: 06/10/2026
SELL
Change
-39,904
Price
Not reported
Filing
06/12/2026
Type
SELL